Femibion
Femibion is a Procter & Gamble-owned brand of phase-specific dietary supplements for women across preconception, pregnancy, breastfeeding, and menopause. Its core differentiator is Folsäure Plus, combining folic acid with bioavailable L-Methylfolat, and it leads gynecologist recommendations in Germany.
- Company typePrivate
- Founded-
- HeadquartersDarmstadt, Germany
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What Femibion does
Femibion is a Procter & Gamble-owned brand of dietary supplements headquartered and marketed from Darmstadt, Germany, serving women across key reproductive and hormonal life stages: preconception (baby planning), each trimester of pregnancy, breastfeeding, and menopause, plus a couples-oriented fertility line. The product portfolio is structured as a phase-specific ladder (Femibion 0 BabyPlanung, 1 Frühschwangerschaft, 2 Schwangerschaft, 3 Stillzeit), supplemented by Femibion Für Sie & Ihn for couples, two Femibion Menopause SKUs (hormone-free hop-extract formulations for hot flashes plus multivitamin support), and iodine-free variants of the trimester products for thyroid-restricted consumers.
The core technological differentiator is the proprietary Folsäure Plus (Folic Acid Plus) formulation, which combines folic acid with L-Methylfolat, the bioactively usable form of folate that bypasses metabolic conversion and helps women reach target folate blood levels within an average of four weeks. The portfolio layers additional phase-relevant nutrients onto this base: choline across the pregnancy and breastfeeding range, 200mg DHA omega-3 fatty acids from the second trimester onward for fetal brain and eye development, iron and iodine for pregnancy-stage demands, and hop extract delivering 8-Prenylnaringenin for the menopause line. Together these constitute a clinically framed, gynecologist-endorsed product architecture rather than a generic multivitamin offering.
Femibion operates a hybrid B2C go-to-market combining direct e-commerce through femibion.de with traditional retail distribution into German pharmacies and drugstores, all under P&G's pan-European Health division infrastructure. Revenue is generated through consumer purchase of 4-, 8-, 12-, and 16-week packs (with subscription options indicated in the source data) rather than enterprise contracts. The brand holds the Nr. 1 gynecologist-recommended position in Germany (Harris Interactive, June 2023, 150 gynecologists) and is the market leader in perinatal vitamin and mineral supplements across 27 Central and Western European countries (IQVIA Global OTC Insights, MAT June 2024).
Femibion firmographics
Firmographics- Name
- Femibion
- Legal name
- Femibion (brand marketed by The Procter & Gamble Company)
- Website
- https://femibion.de
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Femibion is a Procter & Gamble-owned brand of phase-specific dietary supplements for women across preconception, pregnancy, breastfeeding, and menopause. Its core differentiator is Folsäure Plus, combining folic acid with bioavailable L-Methylfolat, and it leads gynecologist recommendations in Germany.
- Ownership category
- akta.pro rank
Femibion industry classification
Industry- Product category
- Prenatal Vitamins and Women's Health Dietary Supplements
- NAICS
- Food Manufacturing (311)
- SIC
- Food And Kindred Products (2000)
- akta.pro primary industry
- Baby Feeding Supplements & Fortifiers (Probiotics, DHA/ARA, Vitamins) (CRADAEAI)
Keywords
Where Femibion is headquartered
LocationHeadquarters
- HQ city
- Darmstadt
- HQ country
- Germany
- HQ region
- Europe
Markets served
Femibion business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Marketing or Sales, Supply Chain, Operations, Technology or R&D
Revenue model
- Direct Consumer Sales: Femibion generates revenue through direct-to-consumer sales of dietary supplements via its official German website (femibion.de) and through retail distribution channels including pharmacies and drugstores throughout Germany and Europe. Products are sold in various pack sizes (4-week, 8-week, 12-week, and 16-week packs) targeting women at different reproductive life stages.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Femibion product offering
Product offeringCore offering
Femibion manufactures and sells phase-specific dietary supplements for women's reproductive health, covering preconception (baby planning), pregnancy trimesters, breastfeeding, and menopause. Core formulations are built on Folsäure Plus (folic acid plus L-Methylfolat) with tailored nutrients for each life stage. Products include Femibion 0 BabyPlanung, Femibion 1 Frühschwangerschaft (with iodine-free variant), Femibion 2 Schwangerschaft (with iodine-free variant), Femibion 3 Stillzeit, Femibion Für Sie & Ihn (couples fertility), and Femibion Menopause lines.
Product overview
Femibion is a line of dietary supplements for women's health spanning pregnancy (from baby planning through breastfeeding) and menopause. The pregnancy line includes Femibion® 0 BabyPlanung (pre-pregnancy), Femibion® 1 Frühschwangerschaft (1st trimester with iodine-free variant), Femibion® 2 Schwangerschaft (2nd/3rd trimester with iodine-free variant), and Femibion® 3 Stillzeit (breastfeeding), all featuring the proprietary Folic Acid Plus formulation combining folic acid and L-methylfolate. The menopause line includes Femibion® Menopause Plus (hopfen extract with multivitamins) and Femibion® Menopause Hitzewallungen (hopfen extract only). An additional product, Femibion® Für Sie & Ihn, supports couples trying to conceive with gender-specific formulations.
Differentiator
Problem solved
Functional benefit
Brands
- Femibion 1 Frühschwangerschaft: Pregnancy vitamin supplements for the 1st trimester with Folsäure Plus and Cholin.
- Femibion 2 Schwangerschaft
- Femibion 3 Stillzeit
- Femibion 0 BabyPlanung
- Femibion Für Sie & Ihn
- Femibion Menopause Hitzewallungen
- Femibion Menopause Plus
Products and services
- Femibion Für Sie & Ihn
Quantifiable outcome
- Achieves desired folate blood levels within average 4 weeks with Folsäure Plus supplementation
- +1 more outcomes
Companies that use Femibion
Customer profileSegments5 records
Ideal customer profiles5 records
Femibion technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Femibion partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Procter & GamblecoreFemibion is owned and marketed by The Procter & Gamble Company and its affiliates. P&G handles product development, manufacturing, and global distribution of the Femibion brand. The products are marketed under P&G Health division. The company leverages P&G's extensive retail distribution network and marketing capabilities.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
Femibion competitors and assessment
Company assessmentDirect peers
- Orthomol: Orthomol is a German specialty supplement manufacturer with a women's health and prenatal product line (e.g., Orthomol Natal). It competes directly with Femibion in Germany through pharmacy channels and physician endorsement, sharing the same gynecologist-recommended, premium micronutrient positioning.
- Doppelherz (Queisser Pharma): Doppelherz is a major German drugstore supplement brand with a dedicated prenatal/maternal product line. It competes with Femibion in German pharmacies and drugstores at a slightly more accessible price point, sharing the same micronutrient-plus-folate positioning for expecting mothers.
- Pregnacare (Vitabiotics): Vitabiotics' Pregnacare is a leading UK-headquartered prenatal supplement range with trimester-specific formulations closely mirroring Femibion's 0/1/2/3 structure. Both brands target gynecologist endorsement, premium positioning, and direct-to-consumer sales in overlapping European markets.
- Elevit (Bayer): Elevit is Bayer's global prenatal vitamin brand and the most direct international competitor to Femibion. Both brands compete head-to-head in the same perinatal vitamin category with similar phase-specific formulations, gynecologist-targeted marketing, and presence across European and global markets.
Broad incumbents
- Nature's Bounty (Nestlé Health Science): Nature's Bounty is a large US-headquartered supplement manufacturer owned by Nestlé Health Science with a dedicated prenatal vitamin range. It overlaps with Femibion in the prenatal category but operates as a broad mass-market supplement portfolio rather than a women's reproductive specialist.
- Centrum (Haleon): Centrum is a broad multivitamin brand owned by Haleon with a dedicated prenatal line (Centrum Materna). It is a much larger incumbent supplement brand with overlap in the prenatal category, but competes as part of a wider vitamin portfolio rather than a specialized women's reproductive line.
- Seven Seas (Haleon): Seven Seas is a Haleon-owned supplement brand with a well-known pregnancy/breastfeeding product line. It overlaps with Femibion in the UK and several European markets, but operates as a broader vitamin, mineral, and cod liver oil brand rather than a women's reproductive specialist.
Others
- New Chapter (Procter & Gamble): New Chapter is a P&G-owned whole-food supplement brand with a prenatal product line. It is a sister brand under the same parent company, sharing Femibion's P&G distribution and marketing backbone, but positioned in the fermented/whole-food supplement niche rather than the synthetic micronutrient category Femibion leads.
Emerging players
- Garden of Life (Nestlé Health Science): Garden of Life is a Nestlé Health Science-owned premium supplement brand with a certified-organic prenatal line targeting health-conscious expectant mothers. It is comparable to Femibion in the premium prenatal segment but focuses on clean-label/organic positioning and is more established in North America than Europe.
Regional players
- Natalben (Italfarmaco): Natalben is an Italfarmaco-owned prenatal supplement brand with strong share in Southern Europe, particularly Spain, Italy, and Portugal. It is comparable to Femibion in product structure (trimester-specific formulations, gynecologist endorsement) but is regionally concentrated rather than pan-European.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Femibion social profiles
Digital presenceFemibion financial estimates
Financial estimateRevenue estimate
Valuation estimate
Femibion leadership team
Management profileNumber of profiles
Femibion funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Femibion M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Femibion
What does Femibion do?
Femibion manufactures and sells phase-specific dietary supplements for women's reproductive health, covering preconception (baby planning), pregnancy trimesters, breastfeeding, and menopause. Core formulations are built on Folsäure Plus (folic acid plus L-Methylfolat) with tailored nutrients for each life stage. Products include Femibion 0 BabyPlanung, Femibion 1 Frühschwangerschaft (with iodine-free variant), Femibion 2 Schwangerschaft (with iodine-free variant), Femibion 3 Stillzeit, Femibion Für Sie & Ihn (couples fertility), and Femibion Menopause lines.
Is Femibion a public or private company?
Femibion is a private company. It is classified as corporate owned and is currently operating.
When was Femibion founded?
Femibion was founded in -1. It employs 11 to 50 people.
Where is Femibion based?
Femibion is headquartered in Darmstadt, Germany, in the Europe region.
How does Femibion make money?
One revenue line is on record: direct Consumer Sales.
Who are Femibion's main competitors?
Direct peers on record are Orthomol, Doppelherz (Queisser Pharma), Pregnacare (Vitabiotics) and Elevit (Bayer). Broad incumbents are Nature's Bounty (Nestlé Health Science), Centrum (Haleon) and Seven Seas (Haleon). New Chapter (Procter & Gamble) is listed as an others. Garden of Life (Nestlé Health Science) is listed as an emerging player. Natalben (Italfarmaco) is listed as a regional player.
Does Femibion have an API?
No public API is recorded for Femibion.
What industry is Femibion in?
Femibion's product category is Prenatal Vitamins and Women's Health Dietary Supplements. Its primary akta.pro industry code is CRADAEAI, Baby Feeding Supplements & Fortifiers (Probiotics, DHA/ARA, Vitamins). Its NAICS code is 311 and its SIC code is 2000.